Healthpeak (DOC) | Financial Analysis & Statements
Healthpeak Properties Inc. Large-cap Real Estate
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
719.4M
Gross Profit
431.5M
59.99%
Operating Income
145.8M
20.27%
Net Income
121.8M
16.93%
Balance Sheet Metrics
Total Assets
20.3B
Total Liabilities
12.0B
Shareholders Equity
8.3B
Debt to Equity
1.45
Cash Flow Metrics
Operating Cash Flow
206.4M
Free Cash Flow
294.1M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Healthpeak Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 2.8B | 2.7B | 2.2B | 2.1B | 1.9B |
| Cost of Goods Sold | 1.1B | 1.1B | 902.1M | 863.0M | 773.3M |
| Gross Profit | 1.7B | 1.6B | 1.3B | 1.2B | 1.1B |
| Gross Margin % | 60.0% | 60.2% | 58.6% | 58.1% | 59.2% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 90.4M | 97.2M | 95.1M | 131.0M | 98.3M |
| Other Operating Expenses | - | - | - | - | - |
| Total Operating Expenses | 90.4M | 97.2M | 95.1M | 131.0M | 98.3M |
| Operating Income | 544.1M | 471.2M | 433.9M | 356.6M | 340.3M |
| Operating Margin % | 19.3% | 17.4% | 19.9% | 17.3% | 17.9% |
| Non-Operating Items | |||||
| Interest Income | - | - | - | - | - |
| Interest Expense | 305.2M | 280.4M | 200.3M | 172.9M | 158.0M |
| Other Non-Operating Income | 45.3M | 82.4M | 81.4M | 323.5M | -54.0M |
| Pre-tax Income | 284.3M | 273.2M | 314.9M | 507.1M | 128.4M |
| Income Tax | 9.3M | 4.4M | -9.6M | -4.4M | -3.3M |
| Effective Tax Rate % | 3.3% | 1.6% | -3.1% | -0.9% | -2.5% |
| Net Income | 101.0M | 267.3M | 334.8M | 516.4M | 525.9M |
| Net Margin % | 3.6% | 9.9% | 15.3% | 25.1% | 27.7% |
| Key Metrics | |||||
| EBITDA | 1.6B | 1.6B | 1.2B | 1.4B | 1.0B |
| EPS (Basic) | $0.10 | $0.36 | $0.56 | $0.92 | $0.93 |
| EPS (Diluted) | $0.10 | $0.36 | $0.56 | $0.92 | $0.93 |
| Basic Shares Outstanding | 696026000 | 675680000 | 547006000 | 538809000 | 538930000 |
| Diluted Shares Outstanding | 696026000 | 675680000 | 547006000 | 538809000 | 538930000 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Healthpeak Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 467.5M | 119.8M | 117.6M | 72.0M | 158.3M |
| Short-term Investments | - | - | - | - | - |
| Accounts Receivable | 78.3M | 76.8M | 55.8M | 53.4M | 48.7M |
| Inventory | - | - | - | - | - |
| Other Current Assets | - | - | - | - | - |
| Total Current Assets | 1.3B | 986.1M | 561.3M | 605.0M | 713.4M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 412.2M | 424.2M | 240.2M | 237.3M | 233.9M |
| Goodwill | 791.6M | 817.3M | 314.2M | 418.1M | 519.8M |
| Intangible Assets | 654.5M | 817.3M | 314.2M | 418.1M | 519.8M |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 996.4M | 942.5M | 772.0M | 780.7M | 674.6M |
| Total Non-Current Assets | 19.0B | 19.0B | 15.1B | 15.2B | 14.5B |
| Total Assets | 20.3B | 19.9B | 15.7B | 15.8B | 15.3B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 263.6M | 276.0M | 240.3M | 265.6M | 227.6M |
| Short-term Debt | 1.1B | 150.0M | 720.0M | 995.6M | 1.2B |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 11.9M | - | 729.0K | 4.1M | 15.1M |
| Total Current Liabilities | 1.8B | 875.3M | 1.4B | 1.8B | 1.9B |
| Non-Current Liabilities | |||||
| Long-term Debt | 9.1B | 8.9B | 6.4B | 5.7B | 5.2B |
| Deferred Tax Liabilities | - | - | - | - | - |
| Other Non-Current Liabilities | 173.7M | 191.9M | 127.4M | 156.2M | 177.2M |
| Total Non-Current Liabilities | 10.2B | 10.0B | 7.4B | 6.7B | 6.2B |
| Total Liabilities | 12.0B | 10.9B | 8.8B | 8.5B | 8.1B |
| Equity | |||||
| Common Stock | 695.0M | 699.5M | 547.2M | 546.6M | 539.1M |
| Retained Earnings | - | - | - | -4.3B | -4.1B |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 8.3B | 9.1B | 6.9B | 7.3B | 7.1B |
| Key Metrics | |||||
| Total Debt | 10.1B | 9.0B | 7.1B | 6.7B | 6.4B |
| Working Capital | -506.6M | 110.8M | -816.6M | -1.2B | -1.2B |
Balance Sheet Composition
Healthpeak Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 101.0M | 267.3M | 334.8M | 516.4M | 525.9M |
| Depreciation & Amortization | 1.0B | 1.1B | 749.9M | 710.6M | 684.3M |
| Stock-Based Compensation | 14.4M | 31.8M | 14.5M | 26.5M | 18.2M |
| Working Capital Changes | 105.7M | 44.8M | -21.6M | 118.9M | 26.4M |
| Operating Cash Flow | 1.1B | 1.3B | 953.3M | 1.2B | 1.1B |
| Investing Activities | |||||
| Capital Expenditures | - | - | - | - | - |
| Acquisitions | -86.8M | -115.2M | -88.4M | 104.8M | -25.3M |
| Investment Purchases | - | - | - | 0 | 0 |
| Investment Sales | - | - | - | - | - |
| Investing Cash Flow | -150.5M | -181.0M | 8.0M | 103.0M | 187.9M |
| Financing Activities | |||||
| Share Repurchases | -97.1M | -190.7M | -6.5M | -67.8M | -12.8M |
| Dividends Paid | -849.1M | -794.8M | -657.0M | -648.0M | -650.1M |
| Debt Issuance | 13.1B | 4.5B | 743.8M | 500.0M | 1.1B |
| Debt Repayment | -12.0B | -4.3B | -10.7B | -16.1B | -18.2B |
| Financing Cash Flow | 136.1M | -941.4M | -11.0B | -16.2B | -17.1B |
| Free Cash Flow | 1.3B | 1.1B | 956.2M | 900.3M | 795.2M |
| Net Change in Cash | 1.1B | 167.9M | -10.0B | -14.8B | -15.8B |
Cash Flow Trend
Healthpeak Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
164.70
Forward P/E
122.00
Price to Book
1.53
Price to Sales
4.06
PEG Ratio
0.11
Profitability Ratios
Profit Margin
2.53%
Operating Margin
20.07%
Return on Equity
1.16%
Return on Assets
1.66%
Financial Health
Current Ratio
1.22
Debt to Equity
122.18
Beta
1.08
Per Share Data
EPS (TTM)
$0.10
Book Value per Share
$10.79
Revenue per Share
$4.06
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| DOC | 11.4B | 164.70 | 1.53 | 1.16% | 2.53% | 122.18 |
| Welltower | 147.1B | 146.65 | 3.44 | 2.54% | 8.64% | 49.49 |
| Ventas | 39.8B | 153.57 | 3.14 | 2.17% | 4.32% | 102.00 |
| Omega Healthcare | 14.1B | 23.69 | 2.62 | 11.98% | 49.59% | 79.02 |
| American Healthcare | 9.6B | 119.29 | 2.80 | 2.50% | 3.09% | 50.20 |
| CareTrust REIT | 8.5B | 23.76 | 2.06 | 9.17% | 67.28% | 71.95 |
Financial data is updated regularly. All figures are in the company's reporting currency.






